Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 40/100

Failure Rate

13.3%

8 terminated/withdrawn out of 60 trials

Success Rate

82.6%

-3.9% vs industry average

Late-Stage Pipeline

33%

20 trials in Phase 3/4

Results Transparency

3%

1 of 38 completed trials have results

Key Signals

6 recruiting1 with results6 withdrawn

Enrollment Performance

Analytics

N/A
17(42.5%)
Phase 4
12(30.0%)
Phase 3
8(20.0%)
Phase 2
2(5.0%)
Phase 1
1(2.5%)
40Total
N/A(17)
Phase 4(12)
Phase 3(8)
Phase 2(2)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (60)

Showing 20 of 60 trials
NCT07569900Not ApplicableRecruiting

A Study to Evaluate the Performance, Usability, and Contrived Result Interpretation of iStatis Gonorrhea Antigen Test

Role: collaborator

NCT07563309Not ApplicableRecruiting

A Study to Evaluate Performance, Usability, and Contrived Result Interpretation of TruPlex HIV/HepB/Syphilis Rapid Test

Role: collaborator

NCT07038837Phase 4Recruiting

Comparison of Two Strategies for Administering the R21-Matrix M Vaccine in a Context of Seasonal Malaria Transmission in Chad

Role: lead

NCT07506213Not ApplicableCompleted

Development, Feasibility and Acceptability of Recipes for Locally Available, Specially Formulated Foods for the Management of Moderate Acute Malnutrition in Niger (Related to NCT06382857 Protocol)

Role: lead

NCT06860178Phase 4Recruiting

Integrating Malaria Vaccine With Seasonal Malaria Chemoprevention in West Africa

Role: lead

NCT05860920Not Yet Recruiting

Clinical Diagnostic Performance Evaluation of a Measles Rapid Test in Senegal

Role: collaborator

NCT05449717Completed

Incidence of Relapse and Post-Kala-Azar Dermal Leishmaniasis in South Sudan

Role: lead

NCT02754765Phase 3Completed

Evaluating Newly Approved Drugs for Multidrug-resistant TB

Role: collaborator

NCT03896685Phase 3Completed

Evaluating Newly Approved Drugs in Combination Regimens for Multidrug-Resistant TB With Fluoroquinolone Resistance (endTB-Q)

Role: collaborator

NCT06715423Not Yet Recruiting

High Flow Nasal Oxygen Therapy an Implementation Study in Pediatric Wards

Role: lead

NCT05175014Phase 4Completed

Mass Campaigns With Fractional Dose Pneumococcal Vaccines in Sub-Saharan Africa (fPCV)

Role: lead

NCT05829772Completed

Impact Study of Cholera Vaccination in Endemic Areas - Seroprevalence

Role: lead

NCT04853186Recruiting

Impact Study of Cholera Vaccination in Endemic Areas - Clinical Surveillance

Role: lead

NCT06382857Not ApplicableRecruiting

Effectiveness of a Microbiome-directed Food to Promote Programmatic and Sustained Nutritional Recovery Among Children With Uncomplicated Acute Malnutrition

Role: lead

NCT05551819Not ApplicableCompleted

Acceptability of a Microbiome-directed Food in Young Children With Acute Malnutrition

Role: lead

NCT02145000Phase 3Completed

Efficacy and Safety of a Pentavalent Rotavirus Vaccine (BRV-PV) Against Severe Rotavirus Gastroenteritis in Niger

Role: lead

NCT05909358Phase 1Not Yet Recruiting

Solidarity/Tokomeza Ebola Trial

Role: collaborator

NCT05075941Completed

Evaluation of Vaccination Coverage and Determinants of Success of the COVID-19 Vaccination Program Among Populations in Very Precarious Situations

Role: lead

NCT05453253Phase 4Unknown

Immune Response to a Delayed Second Dose of Oral Cholera Vaccine

Role: lead

NCT03832023Not ApplicableCompleted

Community-based Tuberculosis Tracing and Preventive Therapy

Role: collaborator